Changes in HIV/AIDS risk behaviors in drug users in St. Louis: Applications of random regression models

Journal of Drug Issues

Volumn 27, Issue 2, 1997, Pages 399-416

  Gallagher, Timothy J ^a   Cottler, Linda B ^b   Compton III, Wilson M ^b   Spitznagel, Edward ^b  

^a KENT STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INTERVIEW; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; SEXUAL BEHAVIOR; UNITED STATES;

EID: 0030749156     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: 10.1177/002204269702700213     Document Type: Article

References (50)

1. Anderson, R.M., and R.M. May 1992 Understanding the AIDS pandemic. Scientific American May:58-66.
2. Battjes, R.J., R.W. Pickens, and Z. Amsel 1991 HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U.S. cities. Journal of Acquired Immune Deficiency Syndromes 4:1148-1154.
3. Becker, M.H., and J.G. Joseph 1988 AIDS and behavioral change to reduce risk: A review. American Journal of Public Health 78(4):394-410.
4. Bloor, M. 1995 The Sociology of HIV Transmission. Thousand Oaks, CA:Sage.
5. Booth, R.E. 1994 Predictors of unsafe needle practices: Injection drug users in Denver. Journal of Acquired Immune Deficiency Syndromes 7:504-508.
6. Booth, R.E., J.K. Watters, and D.D. Chitwood 1993 HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. American Journal of Public Health 83(8):1144-1148.
7. Brooner, R.K., G.E. Bigelow, E. Strain, and C.W. Schmidt 1990 Intravenous drug abusers with antisocial personality disorder: HIV risk behavior. Drug and Alcohol Dependence 26:39-44.
8. Catania, J.A., S. Kegeles, and T.J. Coates 1990 Toward an understanding of risk behavior: An AIDS risk-reduction model. Health Education Quarterly 17:53-92.
9. Centers for Disease Control (CDC) 1995 HIV/AIDS Surveillance Report 7(1) Atlanta:CDC.
10. Compton, W.M., L.B. Cottler, A.M. Shillington, and R.K. Price 1995 Is antisocial personality disorder associated with increased HIV risk behaviors in cocaine users? Drug and Alcohol Dependence 37:37-43.
11. Cottler, L.B., W.M. Compton, R.K. Price, A.M. Shillington, D.J. Claverie, J.E. Works, D.E. Mager, D. Sharma, and O. Miller 1993 St. Louis's efforts to reduce the spread of AIDS. In Innovative Approaches in the Treatment of Drug Abuse: Program Models and Strategies, eds. J.A. Inciardi, F.M. Tims, and B.W. Fletcher. Westport:Greenwood Press.
12. Des Jarlais, D.C., K. Choopanya, S. Vanichseni, K. Plangsringarm, W. Sonchai, W., M. Carballo, P. Friedmann, and S.R. Friedman 1994 AIDS nsk reduction and reduced HIV seroconversion among injection drug users in Bangkok. American Journal of Public Health 84:452-455.
13. Des Jarlais, D.C., and S.R. Friedman 1994 AIDS and the use of injected drugs. Scientific America 270(2):82-88.
14. Des Jarlais, D.C., and S.R. Friedman 1987 HIV infection among drug users, epidemiology and risk reduction. AIDS 1:67-76.
15. Des Jarlais, D.C., S.R. Friedman, and C. Casriel 1990 Target groups for preventing AIDS among intravenous drug users. 2. The 'hard' data studies. Journal of Consulting and Clinical Psychology 58:50-56.
16. Des Jarlais, D.C., S.R. Friedman, D.M. Novick, J.L. Sotheran, P. Thomas, S.R. Yancovitz, D. Mildvan, J. Weber, M.J. Kreek, R. Maslansky, S. Bartelme, T. Spira, and M. Marmor 1989 HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. Journal of the American Medical Association 261:1008-1012.
17. Fisher, J.D., and W.A. Fisher 1992 Changing AIDS-risk behavior. Psychological Bulletin 111:455-474.
18. Gibbons, R.D., D. Hedeker, I. Elkin, C. Waternaux, H.C. Kraemer, J.B. Greenhouse, M.T. Shea, S.D. Imber, S.D., S.M. Sotsky, and J.T. Watkins 1993 Some conceptual and statistical issues in the analysis of longitudinal psychiatric data. Archives of General Psychiatry 50(September):739-750.
19. Gibbons, R.D., D. Hedeker, C. Waternaux, and J.M. Davis 1988 Random regression models: A comprehensive approach to the analysis of aongitudinal psychiatric aata. Psychopharmacology Bulletin 24(3):438-443.
20. Gill, K., D. Nolimal, and T.J. Crowley 1992 Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy. Drug and Alcohol Dependence 30:247-252.
21. Greenfield, L., G.E. Bigelow, and R.K. Brooner 1995 Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors. Drug and Alcohol Dependence 39:91-98.
22. Hedeker, D. 1993 MIXOR: A Fortran Program for Mixed-effects Ordinal Probit and Logistic Regression. U.S. Department of Health and Human Services.
23. Hedeker, D. 1993 MIXREG: A Fortran Program for Mixed-effects Linear Regression Models. U.S. Department of Health and Human Services.
24. Hedeker, D., R.D. Gibbons, and J.M. Davis 1989 Investigating drug plasma levels and clinical response using random regression models. Psychopharmacology Bulletin 25(2):227-231.
25. Hedeker, D., R.D. Gibbons, and J.M. Davis 1991 Random regression models for multicenter clinical trials data. Psychopharmacology Bulletin 27(1):73-77.
26. Hedeker, D., R.D. Gibbons, C. Waternaux, and J.M. Davis 1989 Investigating drug plasma levels and clinical response using random regression models. Psychopharmacology Bulletin 25(2):227-231.
27. Higgins, D.L., C. Galavotti, K.R. O'Reilly, D.J. Schnell, M. Moore, D.L. Rugg, and R. Johnson 1991 Evidence for the effects of HIV antibody counseling and testing on risk behaviors. Journal of the American Medical Association 266(17):2419-2429.
28. Inciardi, J.A., F.M. Tims, and B.W. Fletcher 1993 Innovative Approaches in the Treatment of Drug Abuse: Program Models and Strategies. Westport:Greenwood Press.
29. Khalsa, H.K., M.R. Kowalewski, M.D. Anglin, and J. Wang 1992 HIV-related risk behaviors among cocaine users. AIDS Education and Prevention 4(1):71-83.
30. Kramer, T.H., G. Ottomanelli, and B. Bihari 1992 IV versus non-IV drug use and selected patient variables related to AIDS risk behaviors. The International Journal of the Addictions 27(4):477-485.
31. Laird, N.M. 1988 Missing data in longitudinal studies. Statistics in Medicine 7:305-315.
32. Missouri Department of Health 1995 HIV/STD Statistics. September.
33. Moss, A. 1987 AIDS and intravenous drug use: The real heterosexual epidemic. British Medical Journal 294:389-390.
34. National Institute on Drug Abuse (NIDA) 1988 AIDS initial assessment (AIA) questionnaire. Rockville, MD:Department ot Health and Human Services.
35. National Institute on Drug Abuse (NIDA) 1995 Community Epidemiology Work Group June 1995. Rockville, MD:National Institutes of Health..
36. Neaigus, A., M. Sufian, S.R. Friedman, D.S. Goldsmith, B. Stepherson, P. Mota, J. Pascal, and D.C. Des Jarlais 1990 Effects of outreach intervention on risk reduction among intravenous drug users. AIDS Education and Prevention 2(4):253-271.
37. Price, R.K., L.B. Cottler, D. Mager, S. Keating, and K.S. Murray 1994 Injection drug use, characteristics of significant others and HIV risk behaviors. Nationallnstituteon Drug Abuse Research Monograph Series.
38. Price, R.K., L.B Cottler, W.M. Compton, A.M. Shillington, D. Claverie, G. Asmus, W. Dotson, O. Miller, and M. Horne 1995 Providing free drug abuse treatment to reduce the spread of AIDS in St. Louis: Barriers to care. In Drug Abuse Treatment: The Implementation of Innovative Approaches, eds B.W. Fletcher, J.A. Inciardi, and A.M. Horton. Westport: Greenwood Press.
39. Regier, D.A., M.E. Farmer, D.S. Rae, B.Z. Locke, S.L. Keith, L.L. Judd, and F.K. Goodwin 1990 Comorbidity of mental disorder with alcohol and other drug abuse: Results from the Epidemiological Catchment Area (ECA) study. Journal of the American Medical Association 264(19):2511-2518.
40. Robertson, J.R., A.B.V. Bucknall, P. Welsby, J.J.K. Roberts, J.M. Inglis, J.F. Peutherer, and R.P. Brettle 1986 Epidemic of AIDS-related virus (HTLV-III/LAV) infection among intravenous drug users. British Medical Journal 292:527-529.
41. Robins, L.N, L.B. Cottler, and T. Babor 1990 WHO/ADAMHA Composite International Diagnostic Interview-Substance Abuse Module (SAM). St. Louis:Department of Psychiatry, Washington University School of Medicine.
42. Robins, L.N., J.E. Helzer, L.B. Cottler, and E. Goldring 1989 Diagnostic Interview Schedule, version III-R. St. Louis:Washington University School of Medicine.
43. Rosenstock, I.M., V.J. Strecher, and M.H. Becker 1994 The health belief model and HIV risk behavior change. In Preventing AIDS: Theories and Methods of Behavioral Intervention, eds. R.J. DiClemente and J.L. Peterson, 2-24. New York:Plenum Press.
44. Rounsaville, B.J., S.F. Anton, K. Carroll, D. Budde, and B.A. Prusoff 1991 Psychiatric diagnoses of treatment seeking cocaine abusers. Archives of General Psychiatry 48:43-51.
45. Siegel, H., K. Baumgartner, R. Carlson, et al. 1991 HIV infections and risk behaviours among injectable drug users in low seroprevalence areas in the Midwest. Paper presented at 7th International Conference on AIDS, Florence.
46. Stall, R., L. McKusick, J. Wiley, T.J. Coates, and D.G. Ostrow 1986 Alcohol and drug use during sexual activity and compliance with safe sex guidelines for AIDS: The AIDS Behavioral Research Project. Health Education Quarterly 13(4):359-371.
47. Stephens, R.C., T.E. Feucht, and S.W. Roman 1991 Effects of an intervention program on AIDS-related drug and needle behavior among intravenous drug users. American Journal of Public Health 81(5):568-571.
48. Sterk, C. 1988 Cocaine and HIV seropositivity. Lancet 1:1052-1053.
49. Vanichseni, S., W. Sonchai, K. Plangsringarm, et al. 1989 Second prevalence survey among Bangkok's intravenous drug addicts. Paper presented at 5th International Conference on AIDS, Montreal.
50. World Health Organization (WHO) Collaborative Study Group 1993 An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. Bulletin of Narcotics 45:19-45.